HIGH

Medtronic MiniMed Recalls 1,440 Simplera Sensor Units Over Label Adhesion Risk (2025)

Medtronic MiniMed recalled 1,440 Simplera Sensor units distributed outside the United States after a device cap label may not adhere, risking sterility. The defect could increase infection risk. Patients and healthcare providers should stop using the device and follow recall instructions provided by Medtronic MiniMed or their healthcare provider.

Quick Facts at a Glance

Recall Date
May 7, 2025
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Unknown
At-Risk Groups
GENERAL

Hazard Information

The device cap label may not adhere to the sensor, compromising the sterility of the sensor, and increasing the risk of infection.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

The Simplera Sensor is part of a continuous glucose monitoring system used by people with diabetes to monitor glucose levels.

Why This Is Dangerous

A device cap label may not adhere to the sensor. This can compromise sterility and increase the risk of infection for users.

Industry Context

This recall is not described as part of a broader industry pattern in the provided materials.

Real-World Impact

Consumers outside the US may be affected. Immediate cessation of use is advised to mitigate infection risk and ensure patient safety.

Practical Guidance

How to identify if yours is affected

  1. Verify model REF MMT-5100JD1.
  2. Check Lot HG81GLZ and GTIN 20763000649580.
  3. Confirm distribution country outside the US (Austria, Belgium, Italy, Spain, Switzerland, United Kingdom).

Where to find product info

Recall details available on the FDA enforcement page linked in the notice.

What timeline to expect

Replacement or remedy timelines are not specified; expect guidance from Medtronic MiniMed or healthcare providers.

If the manufacturer is unresponsive

  • File a complaint with the FDA if the manufacturer is unresponsive.
  • Contact your healthcare provider for alternatives and safe usage guidance.
  • Keep documentation of all outreach and responses.

How to prevent similar issues

  • Always verify device labeling and packaging upon receipt.
  • Monitor for sterility indicators and avoid using devices with damaged seals.
  • Stay informed on FDA recalls for medical devices you use.
  • When purchasing medical devices, verify regulatory approvals and recall history.

Documentation advice

Keep recall notification, model and lot numbers, purchase receipts (if available), and all correspondence with the manufacturer or healthcare providers.

Product Details

Model numbers: MMT-5100JD1; Lot HG81GLZ; GTIN 20763000649580. Sold outside the United States in Austria, Belgium, Italy, Spain, Switzerland and the United Kingdom. Recall date: 2025-05-07. Quantity: 1,440 units. Price: Unknown. Remembered recall status: ACTIVE.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 1,440 units recalled
  • REF: MMT-5100JD1
  • European distribution in 6 countries
  • Label adhesion defect risks sterility and infection
  • Status: ACTIVE

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
MMT-5100JD1
HG81GLZ GTIN: 20763000649580
Report Date
October 8, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Medtronic MiniMed 780G Insulin Pump Recalled for 453,144 Units Worldwide (2026)

Medtronic recalled 453,144 MiniMed 780G insulin pumps worldwide after reports of unintended insulin delivery when the pump height changes relative to the infusion site. The defect stems from gravity-driven pressure changes affecting hydrostatic delivery. Patients and caregivers should stop using the devices immediately and follow the recall notice, contacting Medtronic MiniMed or their clinician’s

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed 740G Insulin Pump Recalled for 24,946 Units Worldwide (2026)

Medtronic MiniMed recalled 24,946 MiniMed 740G insulin pumps worldwide after identifying unintended insulin delivery when the pump height changes relative to the infusion site. The defect can cause over-delivery or under-delivery of insulin due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed for instructions on recall steps, refunds or a swap

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Revel Insulin Pumps Recalled: 26,647 Units Worldwide (2026)

Medtronic MiniMed recalled 26,647 Paradigm REAL-Time Revel insulin pumps distributed worldwide, including in the United States. A design flaw can cause insulin to be over- or under-delivered when the pump height changes relative to the infusion site. Patients and health providers should stop using the device immediately and follow the manufacturer’s recall instructions. The recall covers Paradigm,

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed 720G Insulin Pump Recall 2026 Affects 37,458 Units Worldwide

Medtronic MiniMed recalled 37,458 insulin pumps sold worldwide through healthcare providers, including the MiniMed 720G, after finding that a pump raised above or lowered relative to the infusion site can deliver insulin too much or too little. The defect stems from changes in gravitational force affecting hydrostatic and hydrodynamic pressures at the infusion site. Patients should stop using the

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Veo Insulin Pump Recalled for 55,724 Units (2026)

Medtronic MiniMed recalls 55,724 Paradigm REAL-Time Veo insulin pumps distributed worldwide. The pumps can deliver too much insulin when raised or too little when lowered relative to the infusion site due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed or their healthcare provider for instructions and refunds.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Insulin Pumps Recalled 73,656 Units Worldwide in 2026

Medtronic MiniMed recalled 73,656 Paradigm insulin pumps sold worldwide, including broad U.S. distribution, after a risk of unintended insulin delivery. The issue affects Paradigm, 600-series and BLE 700-series pumps. It can cause life-threatening highs or lows in insulin delivery. Stop using the device and follow recall instructions immediately.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed 630G Insulin Pumps Recalled in 2026 for Insulin Delivery Errors (60,880 Units)

Medtronic MiniMed recalled 60,880 insulin pumps sold worldwide through healthcare providers and medical distributors, including the MiniMed 630G line. The defect is gravity related and can cause insulin over-delivery or under-delivery when the pump height changes relative to the infusion site. Patients should stop using the pumps immediately and follow recall instructions.

Medtronic MiniMed
All Medtronic
Read more